Trials / Completed
CompletedNCT03595891
The Study of How Long Participants Stay in the Hospital After Receiving Apixaban for a Blood Clot in the Lung
Apixaban Length-Of-Stay Pulmonary Embolism Study - Hospital Admissions (ALPHA-PE)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 660 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A study based on a chart review of participants that presented with a sudden blood clot in the lung
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interventional | Non-Interventional |
Timeline
- Start date
- 2017-01-20
- Primary completion
- 2021-01-29
- Completion
- 2021-01-29
- First posted
- 2018-07-23
- Last updated
- 2022-05-05
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03595891. Inclusion in this directory is not an endorsement.